Investment Opportunity

15+ Years of Research

INROST is a breakthrough therapeutic injection drug for bone regeneration that significantly accelerates the healing process compared to other methods.

Leap Forward

Completion of the US preclinical studies will increase the company's capitalization to US$ 300 million and significantly increase its investment appeal. Completion of clinical trials (which is beyond the scope of the Second Investment Cycle) will, in turn, increase the company's capitalization to US$ 1 billion.

Market Opportunity

Market Growth Led by Aging

The global available market for bone regeneration products is estimated at US$ 18 billion per annum, including US market reaching up to US$ 2 billion per annum. 

The prevalence of bone fractures is projected to increase due to the aging population and rising incidences of sports injuries and accidents. 

The bone regeneration industry is a rapidly growing sector, with a significant demand for effective and affordable methods for healing bone defects. As the population ages, the incidence of conditions such as osteoporosis and osteoarthritis is also increasing, further driving demand for bone regeneration products.

INROST Advantages

Accelerated Healing

Besides, while being relatively inexpensive to produce and having a long shelf life, the INROST compound is proven to be non-toxic, and not to accumulate in the body. 

Low-Risk Investment

Strong Track Record

Initial preclinical trials and some additional studies have been completed in Russia, the effectiveness of the drug has been confirmed.

Additional studies have shown that the drug is not toxic, does not accumulate in the body, does not disrupt the natural physiological stages of healing and is genetically safe.

Patents have been obtained in the USA, Canada, China, United Kingdom, France, Germany, Japan and Russia.

Ingredients of INROST Bone Regeneration Initiator are already used in medicine

Clinical Contexts

Polytherapeutic Potential

INROST has a broad spectrum of potential applications in medicine. It can be used in traumatology and orthopedics to promote bone regeneration in patients with fractures, non-unions, and bone defects. Moreover, the compound may also benefit plastic surgery, military medicine, sports traumatology, and elite veterinary medicine by reducing complications, improving recovery, and promoting bone healing.
Image
Image
© 2023 INROST Inc., All Rights Reserved